The increase in price target from $11 to $13 by a reputable analyst firm like Piper Sandler suggests a positive outlook on Viatris's stock value in the short term. This adjustment reflects an expectation of improved performance or valuation metrics for Viatris, which could lead to increased investor interest and potentially a rise in stock price.